RecruitingSolid Tumors
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Eligible age
18+ yrs
Accepts
All genders
Locations
12 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors
Sponsor: DualityBio Inc.
Where it's recruiting
California
Los Angeles
Colorado
Wheat Ridge
Florida
Florida City
Georgia
Atlanta
Maryland
Bethesda
Nebraska
Lincoln
New York
New York
Oregon
Portland
South Carolina
Charleston
Texas
Anderson · Houston
Virginia
Virginia Beach
Washington
Puyallup · Spokane
Source: ClinicalTrials.gov · NCT06953089 · last updated 2026-10-29